# Griseofulvin

NDC: 0713-0850
Generic name: Griseofulvin
Labeler / Manufacturer: Cosette Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20221101

FDA application: ANDA065438

## Active ingredients

- GRISEOFULVIN: 125 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0713-0850"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0713-0850
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=67e3ba3c-77e1-43b5-a93c-5bf5e3855780